Welcome to the Industrial Automation website!

NameDescriptionContent
HONG  KANG
E-mail  
Password  
  
Forgot password?
  Register
当前位置:

Global Life Sciences Industry Outlook 2023

来源: | 作者:佚名 | 发布时间 :2023-12-07 | 430 次浏览: | Share:

1. Constantly adjusting portfolio and value creation

In the life sciences, key portfolio decisions that companies are considering today were born at a time of financial disparity. Multiple models and portfolio options are emerging, including the development of potential "blockbuster" drugs, the search for a new generation of therapies, and a focus on diversification. Companies manage to put their capital to work through mergers and acquisitions, which in turn drive these choices. In addition, as interest rates rise and valuations fall, medtech companies are reducing uncertainty within the industry by divesting low-growth and low-margin assets. In doing so, medtech companies can free up capital and improve their financial position in hopes of making them more attractive to strategic acquirers.

Expectations for a recovery in mergers and acquisitions (M&A) have increased, with the majority of M&A activity slowing in 2022, with the number of life sciences deals above $1 billion down 60% from 2021. Still, drug companies with a lot of money at their disposal seem ready to unleash pent-up demand. One of the potential areas of interest for acquirers is multi-indication drugs with potential applications across therapeutic areas, which have the potential to deliver higher returns. However, potential acquirers would need to pay a premium for the drug's versatility.

Life science companies are actively exploring new ways to generate revenue. And a series of developments driving pharmaceutical portfolio realignment involve the emergence of mRNA technology. The anticipation of mRNA technology and the next generation of therapies such as cell and gene therapies will create opportunities for life science companies to increase revenue streams.

Exploring therapeutic innovations, including research into a new generation of therapies, including gene editing, is another area of portfolio expansion for life sciences companies. However, significant challenges remain, particularly the exorbitant upfront costs of developing a CGT and the need for customized manufacturing processes. In addition, due to the ongoing impact of the epidemic, CGT companies are still facing a shortage of raw materials. Life sciences companies may need to consider alternative funding and payment models to accelerate the widespread adoption of their CGT.

In the current environment, companies are rationalizing their underlying assets by divesting non-core assets (assets that do not fit into the overall portfolio, or restructuring and realigning portfolios). Adverse economic conditions have made many deals more attractive.

Ii. Research and Development

According to a Deloitte survey, R&D innovation is one of the top actions that 91% of life sciences companies plan to increase investment in 2023. Life sciences companies will continue to make advances in research and development areas such as translational medicine, big data analytics, and digital innovation. More advanced technologies will also emerge. Given changes in market, regulatory and reimbursement practices, life sciences R&D organizations are under increasing pressure to generate sustainable returns on investment, and companies need to reshape and adapt traditional R&D models.

The growing benefits of Real-world evidence (RWE) help life science businesses better understand disease progression, monitor patient safety, and evaluate clinical and cost effectiveness. While life sciences companies have lagged behind other industries in adopting RWE, RWE is now an increasingly important part of their decision-making process. Businesses are also collecting and analyzing RWE faster.

Traditional clinical development methods have a long process and a success rate of only 10%. Life sciences companies are actively reshaping clinical trials through digital clinical trials, clinical trial simulations, retail clinics, and smart clinical trials to collect data and analyze results digitally. It not only advances the development and regulatory evaluation of new drugs, but also reduces the time and cost of clinical trial cycles, improves patient safety, and solves the issue of medical equity to a certain extent.

AI is becoming increasingly important to drug development, and through AI technology, life science companies can accelerate drug development and time to market, and more accurately predict development costs.

The outbreak has seen an unprecedented level of cooperation and shared services among global regulators, and these collaborations are likely to continue in the coming years. At the same time, life sciences companies are turning to outside suppliers to reduce the time it takes to develop new drugs.

Supply chain is back on the CEO agenda

With repeated outbreaks, geopolitical turmoil affecting shipping and logistics, and inflation at its highest level in 40 years, biotech and pharmaceutical companies are moving away from well-designed, accurate planning in favor of agile supply chains that can be flexible and quickly adapt to changing environments and diverse scenarios. To better understand vulnerabilities in the supply chain, life sciences businesses are exploring a range of practices to enable forward-looking scenario planning and risk mitigation.

  • ABB 3BSE008062R1 PM633 Processor Module
  • ABB L110-24-1 Industrial Control Module
  • ABB IMDSO14 Digital Slave Output Module
  • ABB DSU10 Control Module
  • ABB DSQC627 3HAC020466-001 Advanced Power Supply Module
  • ABB DSQC354 Industrial I/O Module
  • ABB DSQC352 High Performance Input/Output Module
  • ABB 37911-4-0338125 Control Module
  • ABB DSPC172 CPU Module
  • ABB DSBB175 Industrial PLC Expansion Module
  • ABB CR-M4LS Industrial Control Module
  • ABB CI626A 3BSE005029R1 Communication Interface Module
  • ABB BB510 (DC5256) Digital Control Module
  • ABB 61615-0-1200000 High-Precision Industrial Controller
  • ABB 3HNE 00313-1 TILLV.0317 Machine No. 64-25653
  • ABB 3HNA000512-001 Control Module
  • ABB 3HAC025466-001 Industrial Control Module
  • ABB 3HAB8101-8/08Y Industrial Control Module
  • ABB 3BHB003689 Multifunction Controller Module
  • ABB PXBHE65 206-00212 power module
  • ZUNKU 6203-2RS Deep Groove Ball Bearing
  • ZUNKU 6201-2RS Deep Groove Ball Bearing
  • ZYCOM IGLACS01281 Control Module
  • Zygo 8010-0105-02 ZMI-501 Displacement Measurement Interferometer
  • Zygo 1115-801-346 laser head cable
  • ZYGO HSSDC2 TO HSSDC2 CABLE 1115-800-055
  • ZYGO HSSDC TO HSSDC2 CABLE 1115-800-056
  • ZYGO ZMI 4104C Measurement Electronics Board
  • ZYGO ZMI-2002 8020-0211 Measurement Board
  • ZYGO 7702 8070-0102-35 Laser Head
  • ZYGO ZMI 7702 8070-0102-01X Laser Head
  • ZYGO ZMI-4004 4-Axis VME64x Measurement Board
  • ZYGO PC200 CS1115-801-346 Laser interferometer cable
  • ZYGO 8010-0105-01 ZMI Power Supply
  • ZYGO ZMI-2002 8020-0211-1-J Laser system measurement board card
  • ABB 35AE92 control card
  • ABB 200900-004 I/O Adapter PLC Board
  • Siemens 6ES7193-4CA40-0AA0 ET 200S Electronic Module
  • Siemens 6AV2124-2DC01-0AX0 Comfort Panel
  • Siemens 6ES7421-7DH00-0AB0 Digital Input Module
  • Siemens 6ES7350-2AH01-0AE0 Counter Module
  • Siemens 6ES7231-0HC22-0XA0 Analog Input Expansion Module
  • Siemens ET200SP 6ES7193-6PA00-0AA0 server module
  • Siemens 6ES7193-4JA00-0AA0 Terminal Module
  • Siemens 6AG1204-2BB10-4AA3 Ethernet Switch
  • SIEMENS 6GK1105-2AA10 SIMATIC NET series optical switching module (OSM ITP62)
  • Schneider Modicon Quantum 140CPU65260 Unity Processor
  • Schneider Modicon Quantum 140ACO02000 Analog Output Module
  • Schneider Modicon Quantum 140CPS11420 power module
  • Allen-Bradley 1747-CP3 SLC ™ Series of programming cables
  • Kollmorgen S33GNNA-RNNM-00 - Brushless Servo Motor
  • Kollmorgen 6sm56-s3000-g-s3-1325 - Servo Motor
  • Kollmorgen AKM52K-CCCN2-00 - Servo Motor
  • Kollmorgen PSR3-230/75-21-202 - Power Supply
  • Kollmorgen akm24d-anc2r-00 - Servo Motor
  • Kollmorgen AKM22E-ANCNR-00 - Servo Motor
  • Kollmorgen S60300-550 - Servo Drive
  • Kollmorgen B-204-B-21 - Servomotor
  • Kollmorgen AKM21E-BNBN1-00 - Servo Motor
  • Kollmorgen TT2953-1010-B - DC Servo Motor
  • Kollmorgen pa8500 - Servo Power Supply
  • Kollmorgen BDS4A-210J-0001-207C2 - Servo Drive
  • Kollmorgen TTRB1-4234-3064-AA - DC Servo Motor
  • Kollmorgen MH-827-A-43 - Servo Motor
  • Kollmorgen AKM24D-ACBNR-OO - Servo Motor
  • Kollmorgen 00-01207-002 - Servo Disk DC Motor
  • Kollmorgen AKM21C-ANBNAB-00 - Servo Motor
  • Kollmorgen PSR3-208/50-01-003 - Power Supply
  • Kollmorgen 6SM56-S3000 - Servo Motor
  • Kollmorgen DBL3H00130-B3M-000-S40 - Servo Motor
  • Kollmorgen 6SN37L-4000 - Servo Motor
  • Kollmorgen AKM65K-ACCNR-00 - Servo motor
  • Kollmorgen 6SM56-L3000-G - Servo Motor
  • Kollmorgen AKMH43H-CCCNRE5K - Servo Motor
  • Kollmorgen PSR4/52858300 - Power Supply
  • Kollmorgen KBM-79H03-E03 - Direct Drive Rotary Motor
  • Kollmorgen AKM33E-ANCNDA00 - Servo Motor
  • Kollmorgen U9M4/9FA4T/M23 - ServoDisc DC Motor
  • Kollmorgen AKM13C-ANCNR-00 - Servo Motor
  • Kollmorgen AKM43L-ACD2CA00 - Servo Motor
  • Kollmorgen AKM54K-CCCN2-00 - Servo Motor
  • Kollmorgen M-605-B-B1-B3 - Servo Motor
  • Kollmorgen AKD-P00606-NBAN-0000 - Rotary Drive
  • Kollmorgen 6SM-37M-6.000 - Servo Motor
  • Kollmorgen A.F.031.5 - Sercos Interface Board
  • Kollmorgen 918974 5054 - Servo PWM
  • Kollmorgen U12M4 - ServoDisc DC Motor
  • Kollmorgen AKD-B00606-NBAN-0000 - Servo Drive
  • Kollmorgen MV65WKS-CE310/22PB - Servo Drive
  • Kollmorgen 65WKS-CE310/22PB - Servo Drive
  • Kollmorgen EM10-27 - Module
  • Kollmorgen S64001 - Servo Drive
  • Kollmorgen CR03200-000000 - Servo Drive
  • Kollmorgen 6SM57M-3000+G - Servo Motor
  • Kollmorgen BDS4 - Servo Drive
  • Kollmorgen AKD-P00306-NBEC-000 - Servo Drive
  • Kollmorgen AKD-B01206-NBAN-0000 - Servo Drive
  • Kollmorgen STP-57D301 - Stepper Motor
  • Kollmorgen 6SM37L-4.000 - Servo Motor
  • Kollmorgen 44-10193-001 - Circuit Board
  • Kollmorgen PRDR9SP24SHA-12 - Board
  • Kollmorgen PRD-AMPE25EA-00 - Servo Drive
  • Kollmorgen DBL3N00130-0R2-000-S40 - Servo Motor
  • Kollmorgen S406BA-SE - Servo Drive
  • Kollmorgen AKD-P00607-NBEI-0000 - Servo Drive
  • Kollmorgen AKD-P01207-NBEC-0000 - Servo Drive
  • Kollmorgen CR03550 - Servo Drive
  • Kollmorgen VSA24-0012/1804J-20-042E - Servo Drive
  • Kollmorgen N2-AKM23D-B2C-10L-5B-4-MF1-FT1E-C0 - Actuator
  • Kollmorgen 04S-M60/12-PB - Servo Drive
  • Kollmorgen H33NLHP-LNW-NS50 - Stepper Motor
  • Kollmorgen A-78771 - Interlock Board
  • Kollmorgen AKM43E-SSSSS-06 - Servo Motor
  • Kollmorgen AKD-P00607-NBEC-0000 - Servo Drive
  • Kollmorgen E21NCHT-LNN-NS-00 - Stepper Motor
  • Kollmorgen cr10704 - Servo Drive
  • Kollmorgen d101a-93-1215-001 - Motor
  • Kollmorgen BDS4A-203J-0001-EB202B21P - Servo Drive
  • Kollmorgen MCSS23-6432-002 - Connector
  • Kollmorgen AKD-P01207-NACC-D065 - Servo Drive
  • Kollmorgen CK-S200-IP-AC-TB - I/O Adapter and Connector
  • Kollmorgen CR10260 - Servo Drive
  • Kollmorgen EC3-AKM42G-C2R-70-04A-200-MP2-FC2-C0 - Actuator
  • Kollmorgen BDS5A-206-01010-205B2-030 - Servo Drive
  • Kollmorgen s2350-vts - Servo Drive
  • Kollmorgen AKM24D-ANC2DB-00 - Servo Motor
  • Kollmorgen E31NCHT-LNN-NS-01 - Stepper Motor
  • Kollmorgen PRD-0051AMPF-Y0 - Servo Board